Millions Logo
home>US Stocks>Geron
$0.99$-0.26 (-20.80%)in 1 year
As on 13 Nov 2026 at 02:29NASDAQ
52 Week Low: $0.8452 Week High: $2.01

Geron Share Price Today

Geron opened lower at $1.00, compared with its previous close of $1.02. In the last trading session, the stock traded between $0.96 and $1.02. It showed a downward intraday trend.

Return calculator

Time Period

An investment of $100 made 5 years ago in Geron is now worth

$ 64.71

Resulting in a loss of

$ 35.29 (35.29%)

Invest with $1

Note: Past profits do not guarantee future returns.

Analyst Overview

Buy

Rating from 4 Analysts

Buy
75%
Hold
25%
Sell
0%

Markets Today

Today's Change

$-0.03 (-2.94%)

Day High

$1.02

Day Low

$0.96

Day Open

$1.00

Prev Close

$1.02

Volume

90,14,998

1W Return

-7.91%

1M Return

-19.18%

3M Return

-39.08%

6M Return

-28.78%

1Y Return

-20.80%

Fundamentals

Market Cap ($ Mn)

638

PE Ratio

-

PB Ratio

4.42

PEG Ratio

-

ROE

-32.55%

ROCE

-14.16%

EPS (TTM)

$0.00

Investment Returns

1 Week

-7.91%

1 Month

-19.18%

3 Months

-39.08%

6 Months

-28.78%

9 Months

-38.51%

Financials

Quarterly
All values in $ Mn
39.6

Mar 25
49.0

Jun 25
47.2

Sep 25
48.0

Dec 25
57.5

Jun 26
60.2

Sep 26

Updates

4Nov

Geron to present six abstracts on RYTLEO at ASH annual meeting

Geron Corporation will present six abstracts at the 68th ASH Annual Meeting. Presentations cover RYTLEO (imetelstat) in lower-risk myelodysplastic syndromes. Event scheduled for December 12-16, 2026, in New Orleans.

8 days ago
4Nov

Geron Q3FY26 Results: Net revenue rises 27% YoY to $60.1 million

Net revenue rose 27% YoY to $60.1 million, driven by Rytelo demand. Operating expense guidance lowered to $220-$230 million for FY26. Cash position strengthened to $339 million as of September 30, 2026. Rytelo demand grew 10% QoQ with prescribing accounts expanding by 8%. IMPACT MF trial discontinued due to unlikely success on primary endpoint.

8 days ago
20Oct

Geron grants 570,000 stock options to new employees at $1.17

Granted 570,000 stock options to three new employees effective October 16, 2026. Exercise price set at $1.17 per share, matching the closing price on grant date. Options vest over four years, with 12.5% vesting after six months. Grants comply with Nasdaq Listing Rule 5635(c)(4) and the 2018 Inducement Award Plan.

24 days ago
14Oct

Halper Sadeh probes Geron Corp for potential fiduciary duty breaches

Halper Sadeh LLC investigates Geron Corporation for fiduciary breaches. Investigation focuses on officer and director conduct toward shareholders. Firm offers contingent fee representation with no upfront costs. Shareholders may seek governance reforms or financial relief.

1mo ago
26Sep

Halper Sadeh probes Geron Corp over fiduciary duty breaches

Halper Sadeh LLC initiates investigation into Geron Corp for fiduciary duty breaches. Probe focuses on officers and directors regarding shareholder harm. Follows Kahn Swick & Foti investigation into Rytelo disclosure issues. Securities class action lawsuit against Geron remains ongoing.

1mo ago
19Sep

Geron grants 821,250 stock options to nine new hires

Geron granted options to buy 821,250 shares to nine new employees. Exercise price set at $1.32 per share, equal to closing price on Sept 17, 2026. Awards vest over four years starting with 12.5% at six months. Grants comply with Nasdaq Listing Rule 5635(c)(4) as employment inducements.

1mo ago

Similar Stocks

StockLTPChange %Market CapPE
$547.03-0.16%$1,38,692.89M31.55
$61.05+0.38%$1,31,510.31M14.39
$248.69-0.85%$1,00,625.20M-
$959.41+4.73%$97,505.80M19.64
$977.58+0.62%$61,476.10M38.99
$419.98-0.95%$46,108.31M65.60
$180.70-6.40%$39,083.96M-
$53.87-0.37%$33,618.11M26.24
$70.01+0.81%$31,173.07M32.37
$41.85+1.60%$30,322.88M-
$120.75+1.05%$26,490.14M-
$122.27+1.64%$24,922.54M15.85